Traws Pharma, Inc. 8-K Report: Key Updates on Common Stock Events

Here are the key insights extracted from the provided section of the financial report:

1. Entity Information:

• Company Name: Traws Pharma, Inc.
• CIK (Central Index Key): 0001130598
• State of Incorporation: Delaware (DE)
• SEC File Number: 001-36020
• EIN (Employer Identification Number): 22-3627252
• Address: 12 Penns Trail, Newtown, PA 18940
• Phone Number: 267-759-3680

2. Filing Type:

• Form Type: 8-K (a current report used to announce major events that shareholders should know about).

3. Filing Date:

• Date of Filing: December 16, 2024

4. Common Stock Details:

• Type of Security: Common Stock
• Par Value: $0.01 per share
• Ticker Symbol: TRAW
• Exchange: NASDAQ

5. Reporting Period:

• Report Date: December 16, 2024
• The report covers a single date rather than a range, indicating that it may involve a specific event that occurred on that date.

6. Units of Measure:

• The financial information is presented in USD (U.S. Dollars) and shares.

In summary, Traws Pharma, Inc. filed an 8-K report on December 16, 2024, primarily focusing on a specific event related to its common stock, which is traded on NASDAQ under the ticker TRAW. The report includes basic corporate identification and financial details relevant to stakeholders.